Functional Genomics of Chemical -Induced Acute Lung Injury
Functional Genomics of Chemical -Induced Acute Lung Injury
批准号:
7858079
负责人:
George Douglas Leikauf
金额:
$71.4万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-29 至 2011-05-31
关键词:
AcroleinAcute Lung InjuryAlveolarAlveolar CellAmmoniaAntioxidantsBindingBiochemicalCandidate Disease GeneCause of DeathCell ProliferationCell physiologyChemical ExposureChemicalsChlorineClinicalComplexCritical IllnessDataDatabasesDevelopmentDiagnosisEarly DiagnosisEffectivenessElementsEmergency SituationEndothelial CellsEpidermal Growth Factor ReceptorEpithelialEpithelial CellsEpitheliumEquilibriumEventExposure toExtracellular MatrixEyeFGFR2 geneFibrinolysisFibroblastsFoundationsFunctional disorderGastrointestinal tract structureGene ExpressionGene Transfer TechniquesGenesGeneticGenetic DeterminismGoalsGrowthGrowth FactorHazardous ChemicalsHealedHeartHomeostasisHost DefenseHourIndividualInjuryIon TransportKnowledgeLaboratoriesLeadLeukocytesLinkLungMapsMediatingMediator of activation proteinMethodsModelingMolecularMolecular ProfilingMonitorMusNatural ImmunityNeuraxisNickelOrganOutcomeOzonePathway interactionsPatientsPeptide HydrolasesPhosgenePhospholipidsPlantsPlayPopulationPositioning AttributePredispositionProtein BiosynthesisProtein Tyrosine KinaseProteinsPulmonary EdemaPulmonary FibrosisRailroadsRegulationResearch PersonnelRespiratory FailureRespiratory physiologyRiskRoleSignal InductionSignal PathwaySignal TransductionSigns and SymptomsSingle Nucleotide Polymorphism MapStructural ProteinSulfuric AcidsTestingTherapeuticTimeTissue-Specific Gene ExpressionToxic effectTranscriptTransforming Growth Factor alphaTransforming Growth Factor betaTransgenic MiceTraumaTreatment EfficacyTriageWorkWound Healingbasecombatdesignevidence basefunctional genomicsfunctional restorationgenetic linkage analysisgenome wide association studygenome-widehealingimprovedinjury and repairinnovationinsightkeratinocyte growth factorlung injurymortalitymouse modelnovelnovel therapeuticsoutcome forecastprognosticprogramsprotein Breceptorresponsesurfactanttherapeutic development
中文摘要
即使没有外部损伤的迹象,接触化学物质也会对内部靶点造成严重创伤
器官包括肺、心脏、胃肠道、眼睛和中枢神经系统。其中
损伤后,肺损伤的程度往往是生存最关键的。化学性急性肺损伤
(CIALI)可以被视为一个分子级联,在几个小时和几天之后,甚至一个
瞬变事件。不幸的是,CIALI可能是多起恐怖袭击的后果
包括故意引爆化工厂、火车车厢脱轨或化学卡车的情景
劫机。高度关注的化学品包括氯、光气、硫酸、氨和丙烯醛。
预测战略将需要监测形成复杂分子的多个生化指示剂
签名。我们的目标是了解基因、全球转录和分子事件
提供对CIALI机制的见解,并可能重新引导或加强当前的紧急临床
诊断和治疗的方法。这项应用的目的是确定分子
TGFα、FGF7提高该病生存率的作用机制(S)及治疗效果我们的
中心假说是TGFAlpha、Fgf7和TGFbeta信号之间的相互作用决定了
存活并控制对CIALI后遗症的易感性。为了探索我们的假设,我们寻求:
1)确定控制CIALI的遗传决定因素和分子机制
主要危险化学品:氯、光气、硫酸、氨和丙烯醛,2)评估
CIALI期间TGFα和Fgf7的诱导及信号转导的疗效
肺纤维化作为保护的结果是必要的后遗症,以及3)确定分子
在早期开发过程中,5种主要危险化学品各自独有的机制
夏利。在这个项目完成后,我们希望:1)识别决定基因差异的新的遗传差异
对CIALI的敏感性,2)确定在CIALI期间调节的事件,这些事件对多个代理来说是共同的3)
通过CIALI中导致保护的治疗来评估治疗的有效性,4)确定是否有肺
纤维化是在CIALI期间激活TGFα/FGF7信号的不良后果,5)发展为
关于5种主要危险化学品的选择性特征的初始特定化学品数据库。
英文摘要
Even without signs of external injury, chemical exposure can produce severe trauma to internal target
organs including the lungs, heart, gastrointestinal tract, eyes, and the central nervous system. Of these
injuries, the extent of lung injury often is the most critical to survival. Chemical Induced Acute Lung Injury
(CIALI) can be viewed as a molecular cascade mounting over hours and days subsequent to even a
transient incident. Unfortunately, CIALI is a likely consequence of terrorist attacks of multiple possible
scenarios including intentional detonation of chemical plants, railroad car derailment, or chemical truck
hijacking. Chemicals of high concern include chlorine, phosgene, sulfuric acid, ammonia, and acrolein.
Predictive strategies will require the monitoring of multiple biochemical indicators forming complex molecular
signatures. Our goal is to understand the genetic, global transcriptomal, and molecular events that will
provide insights into the mechanisms of CIALI and could redirect or strengthen current emergency clinical
approaches to diagnosis and treatment. The objective of this application is to determine the molecular
mechanism(s) and therapeutic efficacy of TGFalpha and FGF7 in enhancing survival in this condition. Our
central hypothesis is that the interplay between TGFalpha, FGF7, and TGFbeta signaling determines
survival and controls the susceptibility to sequelae from CIALI. To explore our hypothesis, we seek to:
1) Identify the genetic determinants and molecular mechanisms controlling CIALI common to exposure to 5
leading hazardous chemicals: chlorine, phosgene, sulfuric acid, ammonia, and acrolein, 2) Evaluate the
therapeutic efficacy of TGFalpha and FGF7 induction and signaling during CIALI and determine whether
pulmonary fibrosis is a necessary sequela as a consequence of protection, and 3) Identify the molecular
mechanisms that are unique to each of the 5 leading hazardous chemicals during the early development of
CIALI. At the completion of this project, we expect to: 1) Identify novel genetic differences that determine the
susceptibility to CIALI, 2) Identify the events modulated during CIALI that are common to multiple agents 3)
Evaluate the effectiveness of therapies by that lead to protection in CIALI, 4) Determine whether pulmonary
fibrosis is an untoward consequence of activating TGFalpha/FGF7signaling during CIALI, 5) Develop an
initial chemical specific database on the selective signatures of the 5 leading hazardous chemicals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
-
批准号:10708438
-
项目类别:
-
资助金额:$49.93万
-
财政年份:2023
-
负责人:George Douglas Leikauf
-
依托单位:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
-
批准号:10115186
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2020
-
负责人:George Douglas Leikauf
-
依托单位:
Countermeasure Therapeutics for Acute Lung Injury
-
批准号:9207983
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2016
-
负责人:George Douglas Leikauf
-
依托单位:
Countermeasure Therapeutics for Acute Lung Injury
-
批准号:9357593
-
项目类别:
-
资助金额:$19.46万
-
财政年份:2016
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7461274
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7783818
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Role of Metalloproteinases in Mucin Overproduction in COPD
-
批准号:7581036
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2008
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8144632
-
项目类别:
-
资助金额:$75.33万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8323241
-
项目类别:
-
资助金额:$74.44万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8485604
-
项目类别:
-
资助金额:$73.0万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7662563
-
项目类别:
-
资助金额:$70.5万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7498521
-
项目类别:
-
资助金额:$68.94万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7293573
-
项目类别:
-
资助金额:$73.86万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8901168
-
项目类别:
-
资助金额:$69.95万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical-Induced Acute Lung Injury
-
批准号:8694032
-
项目类别:
-
资助金额:$71.55万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Functional Genomics of Chemical -Induced Acute Lung Injury
-
批准号:7224694
-
项目类别:
-
资助金额:$77.22万
-
财政年份:2006
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7159406
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7535986
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7049989
-
项目类别:
-
资助金额:$35.98万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
Growth Factor Protection in Acute Lung Injury
-
批准号:7329821
-
项目类别:
-
资助金额:$35.73万
-
财政年份:2005
-
负责人:George Douglas Leikauf
-
依托单位:
海外基金